Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Apr 14, 2026

Suzy Jackson, a digital health specialist focusing on Patient Tech, highlights the shift in the pharmaceutical industry from a provider-focused model to direct engagement with patients. Using AI to create a more consumer-like, personalized healthcare experience will benefit patients and inform researchers and providers...


Apr 14, 2026

Suzy Jackson, a digital health specialist focusing on Patient Tech, highlights the shift in the pharmaceutical industry from a provider-focused model to direct engagement with patients. Using AI to create a more consumer-like, personalized healthcare experience will benefit patients and inform researchers and providers...


Apr 13, 2026

Dr. Robert Rifkin, medical oncologist and hematologist at the University of Colorado in Steamboat Springs. He was also a clinical investigator in the trial that led to the approval of BLENREP, a multiple myeloma drug from GSK. Multiple myeloma is the second most common blood cancer, and while the prognosis has...


Apr 13, 2026

Dr. Robert Rifkin, medical oncologist and hematologist at the University of Colorado in Steamboat Springs. He was also a clinical investigator in the trial that led to the approval of BLENREP, a multiple myeloma drug from GSK. Multiple myeloma is the second most common blood cancer, and while the prognosis has...


Apr 9, 2026

Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform...